Search and volunteer to participate in these available studies at UB. Your participation in research doesn't just benefit you, it helps advance healthcare for our entire community.

Highlighted Searches
Search Clinical Trials
Filter on any fields below
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Enrollment Update

Due to COVID-19, new enrollment in research studies will be greatly limited. If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry. View the guidance for research participants for additional information.

Showing 1 - 10 of 307 Clinical Trials
Description:
This study enrolls adults who have tested positive for COVID-19 and are currently hospitalized. The purpose of this study is to learn whether giving donor plasma collected from patients who have recovered from COVID-19 infection to those who are having symptoms now helps with recovery. Read More
Eligibility:
Adults ages 18+.
SARS-CoV-2 positive test within the past 14 days.
Currently hospitalized or in an emergency department with anticipated hospitalization.
Symptoms of acute respiratory infection.
Contact(s)
CATHERINE WRONA
wrona@buffalo.edu
+1 716-888-4713
Description:
This study enrolls teens ages 12-17. The purpose of the study is to learn more about how people in this age group record what they eat and drink compared to how they answer surveys about what they eat and drink. Read More
Eligibility:
Children/Adolescents ages 12-17.
Child owns a smartphone with data access
Child is willing to attend 1 in-person visit (UB South) or one remote visit (via zoom) with one parent or guardian.
Child is willing to answer randomly texted surveys throughout the day (up to 6) plus complete a survey before bed for one week.
Contact(s)
AMANDA ZIEGLER
Amz9@buffalo.edu
+1 716-829-2022
Description:
This study enrolls adults with or without hearing loss. The purpose of this study is to learn more about the connection between tinnitus (a ringing in the ears), hyperacusis (noise sensitivity) and cognition (how people think). Read More
Eligibility:
Adults ages 18+.
May or may not have hearing loss.
Contact(s)
ADAM SHEPPARD
asheppar@buffalo.edu
+1 716-829-2797
Description:
This study enrolls adults with aortic valve stenosis. The purpose of this study is to show whether using Sentinel, a medical device to collect debris, Read More
Eligibility:
Adults ages 18+.
Diagnosed with severe aortic valve stenosis.
Scheduled to undergo a transcatheter aortic valve replacement (TAVR).
Contact(s)
ROBIN STEIN
rmstein3@buffalo.edu
+1 716-888-4859
Description:
This study enrolls people with TRK fusion cancer. The purpose of this study is to learn more about the effectiveness of the drug VITRAKVI (generic name: larotrectinib) for TRK fusion cancer that has spread from the place where it started to other places in the body. TRK fusion cancer is a term used to describe a variety of common and rare cancers that are caused by a change to the NTRK (Neurotrophic Tyrosine Kinase) gene called a fusion. VITRAKVI is an approved drug that blocks the action of the NTRK gene fusion. Read More
Eligibility:
Adults 18+
Patients with TRK fusion cancer (locally advanced or metastatic solid tumor harboring an NTRK gene fusion).
Your physician has decided to treat you with larotrectinib.
Contact(s)
Deonna Coleman
dc84@buffalo.edu
Description:
This study enrolls adults with esophageal cancer. The purpose of this study is to compare the effects of different combinations of medications to treat this cancer. Atezolizumab and tiragolumab are experimental drugs, which means the U.S. Food and Drug Administration (FDA) has not approved them, alone or in combination, for the treatment of esophageal cancer. Read More
Eligibility:
Adults ages 18+.
Diagnosed with esophageal cancer (squamous cell carcinoma of the esophagus) in stage II-IIVA.
The cancer is unresectable, which means you are unable to unwilling to have surgery.
You have received chemoradiotherapy and your disease did not worsen.
Contact(s)
Deonna Coleman
dc84@buffalo.edu
Description:
This study enrolls adults who have been diagnosed with borderline personality disorder. This study is being done to see if the study drug called, BI 1358894, may help people with BPD in the future. Read More
Eligibility:
Adults ages 18-65 years.
Diagnosed with Borderline Personality Disorder.
Contact(s)
SEVIE KANDEFER
sk293@buffalo.edu
+1 716-898-4038
Description:
This study enrolls children and teens. The purpose of the study is to see which types of toothpaste give the most benefit to teeth. Read More
Eligibility:
Children ages 10-14.
Presence of second molars or evidence of erupting permanent second molars.
Good general health
Contact(s)
ALLANA LANGEN
alangen@buffalo.edu
+1 716-888-4712
Description:
This study enrolls people with Multiple Sclerosis who have already enrolled in the New York State Multiple Sclerosis Consortium (NYSMSC). The purpose of this study is to learn more about the experiences of people with MS who are having a natalizumab infusion. Read More
Eligibility:
Adults ages 18+.
Have multiple sclerosis.
Are enrolled in the New York State Multiple Sclerosis Consortium (NYSMSC),
Have taken natalizumab for the treatment of MS for at least six months.
Contact(s)
CAILA VAUGHN
hilbert2@buffalo.edu
+1 716-859-3393
Description:
This study enrolls adults ages 18-45. The purpose of this study is to learn more about people's thoughts about the future and exercise. Read More
Eligibility:
Adults ages 18-45.
Have access to smartphone or wi-fi connected tablet.
Are able to do moderate physical activity.
Contact(s)
CATHERINE GUTH
ciguth@buffalo.edu
+1 716-829-5666
Showing 1 - 10 of 307 Clinical Trials
Not finding what you are looking for? Add your profile to the Buffalo Research Registry and we will try to match you up with future studies.
Buffalo Research Registry